ALR Technologies SG Ltd ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces it has entered into a Letter of Intent ("LOI") to acquire 100% equity of CGM Medical ...
Emerging evidence points to potential benefits of continuous glucose monitoring (CGM) well beyond use as a management tool for people with diabetes who use insulin. Until recently, CGM use had been ...
A recent systematic review and meta-analysis published in Diabetes, Obesity and Metabolism in 2025 demonstrates that ...
Introducing continuous glucose monitoring in primary care optimizes diabetes management in underserved populations.
Among insulin-treated, CGM-naive adults, CGM initiation in primary care produced larger HbA1c reductions at 12 months and ...
Zacks Investment Research on MSN
Here's why you should retain DexCom stock in your portfolio for now
DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...
SINGAPORE, June 25, 2025 /PRNewswire/ -- ALR Technologies SG Ltd. (ALRTF), the diabetes management company, announces it has entered into a Definitive Manufacturing Agreement with CGM Medical ...
Leveraging rapid technological advances for human health is a global trend, driving the rise of biomedical engineering research. An interdisciplinary research team, including the Faculty of ...
AI can help read CGM data for glucose forecasts, but broader health profiling still faces validation, privacy, and governance limits.
Please provide your email address to receive an email when new articles are posted on . Continuous glucose monitors can provide information about glucose to people who don’t have diabetes, including ...
ALR Technologies SG Ltd ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces it has entered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results